Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-21
DOI
10.3389/fimmu.2019.01921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells
- (2019) Esraah Alharris et al. Oncotarget
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
- (2018) Floriana De Angelis et al. CNS DRUGS
- MicroRNA-30 modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages
- (2018) Kathryn Miranda et al. INTERNATIONAL JOURNAL OF OBESITY
- Progressive multiple sclerosis, cognitive function, and quality of life
- (2018) Helene Højsgaard Chow et al. Brain and Behavior
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- MicroRNA-92a Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis
- (2018) Nahid Rezaei et al. INFLAMMATION
- MicroRNA-21 silencing prolongs islet allograft survival by inhibiting Th17 cells
- (2018) Hui Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
- (2017) Debra A. Kendall et al. Frontiers in Cellular Neuroscience
- Multiple sclerosis: Pathology, diagnosis and treatments
- (2017) Wen-Juan Huang et al. Experimental and Therapeutic Medicine
- miR-21 silencing ameliorates experimental autoimmune encephalomyelitis by promoting the differentiation of IL-10-producing B cells
- (2017) Hui Wang et al. Oncotarget
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
- (2017) Sabrina Giacoppo et al. Multiple Sclerosis and Related Disorders
- MicroRNAs mediating CNS inflammation: Small regulators with powerful potential
- (2016) Wei Su et al. BRAIN BEHAVIOR AND IMMUNITY
- RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation
- (2016) Xiaoming Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
- (2016) Jessica M. Sido et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- miRNAs Participate in MS Pathological Processes and Its Therapeutic Response
- (2016) Ting Wu et al. MEDIATORS OF INFLAMMATION
- Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
- (2016) Francesca Ronchi et al. Nature Communications
- A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
- (2015) A Feliú et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis
- (2015) Gopal Murugaiyan et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
- (2015) Venkatesh L. Hegde et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3
- (2015) Lingyun Zhang et al. Nature Communications
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Staphylococcal Enterotoxin B-Induced MicroRNA-155 Targets SOCS1 To Promote Acute Inflammatory Lung Injury
- (2014) Roshni Rao et al. INFECTION AND IMMUNITY
- Histone Modifications Are Associated with Δ9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses
- (2014) Xiaoming Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells
- (2013) Michael Rouse et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting translational control as a novel way to treat inflammatory disease: the emerging role of MicroRNAs
- (2013) M. Plank et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
- (2013) Tobias Goldmann et al. NATURE NEUROSCIENCE
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
- (2013) Sofia Sisay et al. PLoS One
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNAs: Novel Regulators of Oligodendrocyte Differentiation and Potential Therapeutic Targets in Demyelination-Related Diseases
- (2012) Jia-Su Li et al. MOLECULAR NEUROBIOLOGY
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Δ9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2
- (2012) Peer W. F. Karmaus et al. TOXICOLOGICAL SCIENCES
- Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
- (2011) Silvia Rossi et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers
- (2011) Filippo Martinelli-Boneschi et al. NEUROSCIENCE LETTERS
- Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
- (2011) Venkatesh L. Hegde et al. PLoS One
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
- (2010) Ryan M. O'Connell et al. IMMUNITY
- miRNAs in multiple sclerosis: Regulating the regulators
- (2010) Mireia Guerau-de-Arellano et al. JOURNAL OF NEUROIMMUNOLOGY
- The emerging role of microRNAs in multiple sclerosis
- (2010) Andreas Junker et al. Nature Reviews Neurology
- Human natural Treg microRNA signature: Role of microRNA‐31 and microRNA‐21 in FOXP3 expression
- (2009) Redouane Rouas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cannabinoids as novel anti-inflammatory drugs
- (2009) Prakash Nagarkatti et al. Future Medicinal Chemistry
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection
- (2008) Catherine A. Newton et al. Journal of Neuroimmune Pharmacology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search